Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

NEELAPU, SATTVA S

One or more keywords matched the following items that are connected to NEELAPU, SATTVA S

Item Type	Name
Concept	Receptors, Antigen, T-Cell, alpha-beta
Concept	Receptors, Antigen, T-Cell
Concept	Receptors, Antigen, B-Cell
Academic Article	A novel strategy for rapid and efficient isolation of human tumor-specific CD4(+) and CD8(+) T-cell clones.
Academic Article	Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen.
Academic Article	Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs.
Academic Article	Chimeric Antigen Receptor T Cells in Hematologic Malignancies.
Academic Article	Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.
Academic Article	CAR T-Cell Therapy in Large B-Cell Lymphoma.
Academic Article	Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
Academic Article	Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'.
Academic Article	Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy.
Academic Article	The promise of CAR T-cell therapy in aggressive B-cell lymphoma.
Academic Article	ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Academic Article	Chimeric Antigen Receptor-Engineered T Cell Therapy in Lymphoma.
Academic Article	Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance.
Academic Article	CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity.
Academic Article	Managing the toxicities of CAR T-cell therapy.
Academic Article	Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Academic Article	Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy.
Academic Article	Development and Use of the Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Axicabtagene Ciloleucel in Large B-Cell Lymphoma: A Review.
Academic Article	The chimeric antigen receptor-intensive care unit (CAR-ICU) initiative: Surveying intensive care unit practices in the management of CAR T-cell associated toxicities.
Academic Article	Chimeric antigen receptor T-cell therapy toxicities.
Academic Article	Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas.
Academic Article	How I Manage: Pathophysiology and Management of Toxicity of Chimeric Antigen Receptor T-Cell Therapies.
Academic Article	Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma.
Academic Article	Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy.
Academic Article	Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies.
Academic Article	Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy.
Academic Article	Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma.
Academic Article	Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma.
Academic Article	Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses.
Academic Article	CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights.
Academic Article	Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy.
Academic Article	A single-cell atlas of CD19 chimeric antigen receptor T?cells.
Academic Article	Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy.
Academic Article	Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas.
Academic Article	A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting Aspergillus fumigatus.

Search Criteria

Receptors Antigen